Carvedilol Tablets 3.125mg

Pays: Nouvelle-Zélande

Langue: anglais

Source: Medsafe (Medicines Safety Authority)

Ingrédients actifs:

Carvedilol 3.125mg;  ;  

Disponible depuis:

Norton Healthcare Limited (NZ)

DCI (Dénomination commune internationale):

Carvedilol 3.125 mg

Dosage:

3.125 mg

forme pharmaceutique:

Tablet

Composition:

Active: Carvedilol 3.125mg     Excipient: Colloidal silicon dioxide Crospovidone Iron oxide red Iron oxide yellow Lactose monohydrate Magnesium stearate Povidone

Unités en paquet:

Blister pack, White opaque PVC/PVdC-Alu blister srips packaged in printed carton, 30 tablets

classe:

Prescription

Type d'ordonnance:

Prescription

Fabriqué par:

Plantex Ltd

indications thérapeutiques:

Carvedilol tablets are indicated for the management of essential hypertension. It can be used alone or in combination with other antihypertensive agents (eg calcium channel blockers, diuretics).

Descriptif du produit:

Package - Contents - Shelf Life: Blister pack, White opaque PVC/PVdC-Alu blister srips packaged in printed carton - 30 tablets - 24 months from date of manufacture stored at or below 25°C

Date de l'autorisation:

2006-08-16